[New post] Can the Public Benefit Company Structure Save US Healthcare?

sjwilliamspa posted: " Can the Public Benefit Company Structure Save US Healthcare? Curator: Stephen J. Williams, Ph.D. According to Centers for Medicare and Medicare Services (CMS.gov) healthcare spending per capita has reached 17.7 percent of GDP with, according to CMS" New post on Leaders in Pharmaceutical Business Intelligence (LPBI) Group Can the Public Benefit Company Structure Save US Healthcare? by sjwilliamspa Can the Public Benefit Company Structure Save US Healthcare? Curator: Stephen J. Williams, Ph.D. According to Centers for Medicare and Medicare Services (CMS.gov) healthcare spending per capita has reached 17.7 percent of GDP with, according to CMS data: From 1960 through 2013, health spending rose from $147 per person to $9,255 per person, an average […] Read more of this post sjwilliamspa | August 20, 2021 at 10:57 am | Tags: aca, Affordable Healthcare Act, health economics, healthcare, healthcare cost, healthinequity, Medicaid, medical costs, medicare costs, Patient care, public benefit company, rural healthcare | Categories: Accountable Care Organizations, Affordable Care Act, and Bioethics, Centers for Medicare & Medicaid Services, Federal Budget Appropriations, Health Care System by Country, Health Economics and Outcomes Research, Health Law & Patient Safety, Health Law Policy, Healthcare costs and reimbursement, HealthCare IT, Healthcare Reform, Hospital reputation, Law and Medicine Conflicts, Leadership, Power, Social Interlocking Connections, Patient Experience, Patient Outlook, Population Health Management, Population Health Management, Genetics & Pharmaceutical, Support Staff, U.S. Employment-to-Population Ratio, United States, Value-based Drug Pricing | URL: https://wp.me/p2kEDv-gYk Comment    See all comments Unsubscribe to no longer receive posts from Leaders in Pharmaceutical Business Intelligence (LPBI) Group. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://pharmaceuticalintelligence.com/2021/08/20/can-the-public-benefit-company-structure-save-us-healthcare/